A randomized controlled pilot study assessing the effect of sitagliptin on the preservation of beta-cell function in patients with type 2 diabetes.
Phase of Trial: Phase II
Latest Information Update: 28 Dec 2011
At a glance
- Drugs Metformin; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms BEST
- 30 Jun 2010 Status changed from active, no longer recruiting to completed, based on the results being presented at the 70th Annual Scientific Sessions of the American Diabetes Association.
- 30 Jun 2010 Presented at the 70th Annual Scientific Sessions of the Amercian Diabetes Association
- 14 Dec 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History